期刊论文详细信息
Infectious Diseases and Therapy | |
Response to McGirr et al.'s Comment on “Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada” | |
Maarten Postma1  Taj Jadavji2  Francois Peloquin3  Marie-Claude Breton3  Raymond Farkouh4  Matt Wasserman4  Heather L. Sings4  Cheryl McDade5  Stephanie R. Earnshaw5  Michele R. Wilson5  | |
[1] Department of Pharmacy, University of Groningen;Departments of Pediatrics, Microbiology, Immunology, and Infectious Diseases, Faculty of Medicine, Cumming School of Medicine, University of Calgary;Pfizer Canada Inc.;Pfizer Inc.;RTI Health Solutions; | |
关键词: Cost-effectiveness; Health economics; Pneumococcal disease; Vaccination; | |
DOI : 10.1007/s40121-018-0221-2 | |
来源: DOAJ |
【 授权许可】
Unknown